Germinal centers may mean poor outcomes in thymoma-associated MG
A study of patients with thymoma-associated MG found that germinal centers in the thymic tissue lower the incidence of minimal manifestations.
A study of patients with thymoma-associated MG found that germinal centers in the thymic tissue lower the incidence of minimal manifestations.
Severe myasthenia gravis symptoms mean a higher anxiety and depression risk, though no causal genetic link was found, a new study says.
Most patients with generalized myasthenia gravis saw meaningful symptom improvement within four weeks of treatment with efgartigimod.
Efgartigimod works faster than the current standard therapy in helping patients with MG recover from an impending myasthenic crisis.
The age of MG symptoms onset has gotten significantly older in the past five decades, with very late onset making up 45% of new diagnoses.
Patient-reported breathing symptoms did not reliably match lung function test results, indicating objective testing remains essential in MG.
Patients with MG face more complications after heart surgery, though survival rates are the same as for other patients, a new study found.
A new study found that immune checkpoint inhibitors may cause life-threatening complications when used to treat thymomas in people with MG.
Patients and doctors often think alike on the treatment of generalized MG, but some important gaps in communication still exist.
Glucocorticoids are a cornerstone of MG treatment, but prolonged use can lead to complications and higher healthcare costs.